nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2A6—Progesterone—uterine cancer	0.125	0.184	CbGbCtD
Bupropion—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0928	0.137	CbGbCtD
Bupropion—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0648	0.0956	CbGbCtD
Bupropion—CYP2C8—Progesterone—uterine cancer	0.0615	0.0908	CbGbCtD
Bupropion—CYP1A2—Progesterone—uterine cancer	0.0476	0.0703	CbGbCtD
Bupropion—CYP2C9—Progesterone—uterine cancer	0.0429	0.0633	CbGbCtD
Bupropion—CYP2D6—Progesterone—uterine cancer	0.0392	0.0579	CbGbCtD
Bupropion—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0377	0.0556	CbGbCtD
Bupropion—CYP2E1—Etoposide—uterine cancer	0.0368	0.0544	CbGbCtD
Bupropion—CYP2C8—Etoposide—uterine cancer	0.0275	0.0406	CbGbCtD
Bupropion—CYP3A4—Progesterone—uterine cancer	0.0249	0.0368	CbGbCtD
Bupropion—CYP2B6—Doxorubicin—uterine cancer	0.0248	0.0366	CbGbCtD
Bupropion—CYP1A2—Etoposide—uterine cancer	0.0213	0.0315	CbGbCtD
Bupropion—CYP2D6—Doxorubicin—uterine cancer	0.012	0.0177	CbGbCtD
Bupropion—CYP3A4—Etoposide—uterine cancer	0.0112	0.0165	CbGbCtD
Bupropion—CYP3A4—Doxorubicin—uterine cancer	0.00761	0.0112	CbGbCtD
Bupropion—Hypotension—Etoposide—uterine cancer	0.000123	0.000384	CcSEcCtD
Bupropion—Gastritis—Doxorubicin—uterine cancer	0.000123	0.000384	CcSEcCtD
Bupropion—Muscular weakness—Doxorubicin—uterine cancer	0.000122	0.000383	CcSEcCtD
Bupropion—Dysuria—Epirubicin—uterine cancer	0.000121	0.000379	CcSEcCtD
Bupropion—Abdominal distension—Doxorubicin—uterine cancer	0.00012	0.000377	CcSEcCtD
Bupropion—Upper respiratory tract infection—Epirubicin—uterine cancer	0.00012	0.000377	CcSEcCtD
Bupropion—Influenza—Doxorubicin—uterine cancer	0.00012	0.000375	CcSEcCtD
Bupropion—Dysphagia—Doxorubicin—uterine cancer	0.00012	0.000375	CcSEcCtD
Bupropion—Asthma—Doxorubicin—uterine cancer	0.00012	0.000375	CcSEcCtD
Bupropion—Pollakiuria—Epirubicin—uterine cancer	0.000119	0.000374	CcSEcCtD
Bupropion—Photosensitivity reaction—Epirubicin—uterine cancer	0.000118	0.00037	CcSEcCtD
Bupropion—Paraesthesia—Etoposide—uterine cancer	0.000118	0.000369	CcSEcCtD
Bupropion—Weight increased—Epirubicin—uterine cancer	0.000118	0.000369	CcSEcCtD
Bupropion—Pancreatitis—Doxorubicin—uterine cancer	0.000117	0.000368	CcSEcCtD
Bupropion—Weight decreased—Epirubicin—uterine cancer	0.000117	0.000367	CcSEcCtD
Bupropion—Dyspnoea—Etoposide—uterine cancer	0.000117	0.000366	CcSEcCtD
Bupropion—Hyperglycaemia—Epirubicin—uterine cancer	0.000117	0.000366	CcSEcCtD
Bupropion—Somnolence—Etoposide—uterine cancer	0.000117	0.000365	CcSEcCtD
Bupropion—Pneumonia—Epirubicin—uterine cancer	0.000116	0.000363	CcSEcCtD
Bupropion—Infestation NOS—Epirubicin—uterine cancer	0.000115	0.000361	CcSEcCtD
Bupropion—Infestation—Epirubicin—uterine cancer	0.000115	0.000361	CcSEcCtD
Bupropion—Vomiting—Dactinomycin—uterine cancer	0.000115	0.000361	CcSEcCtD
Bupropion—Bronchitis—Doxorubicin—uterine cancer	0.000115	0.000361	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000114	0.000358	CcSEcCtD
Bupropion—Rash—Dactinomycin—uterine cancer	0.000114	0.000358	CcSEcCtD
Bupropion—Decreased appetite—Etoposide—uterine cancer	0.000114	0.000357	CcSEcCtD
Bupropion—Pancytopenia—Doxorubicin—uterine cancer	0.000114	0.000356	CcSEcCtD
Bupropion—Gastrointestinal disorder—Etoposide—uterine cancer	0.000113	0.000355	CcSEcCtD
Bupropion—Fatigue—Etoposide—uterine cancer	0.000113	0.000354	CcSEcCtD
Bupropion—Neuropathy peripheral—Epirubicin—uterine cancer	0.000113	0.000354	CcSEcCtD
Bupropion—Stomatitis—Epirubicin—uterine cancer	0.000112	0.000352	CcSEcCtD
Bupropion—Jaundice—Epirubicin—uterine cancer	0.000112	0.000352	CcSEcCtD
Bupropion—Pain—Etoposide—uterine cancer	0.000112	0.000352	CcSEcCtD
Bupropion—Constipation—Etoposide—uterine cancer	0.000112	0.000352	CcSEcCtD
Bupropion—Conjunctivitis—Epirubicin—uterine cancer	0.000112	0.000351	CcSEcCtD
Bupropion—Urinary tract infection—Epirubicin—uterine cancer	0.000112	0.000351	CcSEcCtD
Bupropion—Dysuria—Doxorubicin—uterine cancer	0.000112	0.000351	CcSEcCtD
Bupropion—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000111	0.000348	CcSEcCtD
Bupropion—Sweating—Epirubicin—uterine cancer	0.000111	0.000346	CcSEcCtD
Bupropion—Pollakiuria—Doxorubicin—uterine cancer	0.000111	0.000346	CcSEcCtD
Bupropion—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000109	0.000342	CcSEcCtD
Bupropion—Weight increased—Doxorubicin—uterine cancer	0.000109	0.000341	CcSEcCtD
Bupropion—Epistaxis—Epirubicin—uterine cancer	0.000109	0.000341	CcSEcCtD
Bupropion—Weight decreased—Doxorubicin—uterine cancer	0.000108	0.000339	CcSEcCtD
Bupropion—Sinusitis—Epirubicin—uterine cancer	0.000108	0.000339	CcSEcCtD
Bupropion—Feeling abnormal—Etoposide—uterine cancer	0.000108	0.000339	CcSEcCtD
Bupropion—Hyperglycaemia—Doxorubicin—uterine cancer	0.000108	0.000338	CcSEcCtD
Bupropion—Nausea—Dactinomycin—uterine cancer	0.000108	0.000337	CcSEcCtD
Bupropion—Pneumonia—Doxorubicin—uterine cancer	0.000107	0.000336	CcSEcCtD
Bupropion—Gastrointestinal pain—Etoposide—uterine cancer	0.000107	0.000336	CcSEcCtD
Bupropion—Infestation NOS—Doxorubicin—uterine cancer	0.000107	0.000334	CcSEcCtD
Bupropion—Infestation—Doxorubicin—uterine cancer	0.000107	0.000334	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000106	0.000331	CcSEcCtD
Bupropion—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000105	0.000328	CcSEcCtD
Bupropion—Urticaria—Etoposide—uterine cancer	0.000104	0.000327	CcSEcCtD
Bupropion—Haemoglobin—Epirubicin—uterine cancer	0.000104	0.000326	CcSEcCtD
Bupropion—Stomatitis—Doxorubicin—uterine cancer	0.000104	0.000326	CcSEcCtD
Bupropion—Jaundice—Doxorubicin—uterine cancer	0.000104	0.000326	CcSEcCtD
Bupropion—Rhinitis—Epirubicin—uterine cancer	0.000104	0.000325	CcSEcCtD
Bupropion—Body temperature increased—Etoposide—uterine cancer	0.000104	0.000325	CcSEcCtD
Bupropion—Abdominal pain—Etoposide—uterine cancer	0.000104	0.000325	CcSEcCtD
Bupropion—Urinary tract infection—Doxorubicin—uterine cancer	0.000104	0.000325	CcSEcCtD
Bupropion—Conjunctivitis—Doxorubicin—uterine cancer	0.000104	0.000325	CcSEcCtD
Bupropion—Haemorrhage—Epirubicin—uterine cancer	0.000104	0.000324	CcSEcCtD
Bupropion—Hepatitis—Epirubicin—uterine cancer	0.000104	0.000324	CcSEcCtD
Bupropion—Hypoaesthesia—Epirubicin—uterine cancer	0.000103	0.000323	CcSEcCtD
Bupropion—Pharyngitis—Epirubicin—uterine cancer	0.000103	0.000322	CcSEcCtD
Bupropion—Sweating—Doxorubicin—uterine cancer	0.000102	0.00032	CcSEcCtD
Bupropion—Urinary tract disorder—Epirubicin—uterine cancer	0.000102	0.00032	CcSEcCtD
Bupropion—Oedema peripheral—Epirubicin—uterine cancer	0.000102	0.000319	CcSEcCtD
Bupropion—Connective tissue disorder—Epirubicin—uterine cancer	0.000102	0.000319	CcSEcCtD
Bupropion—Urethral disorder—Epirubicin—uterine cancer	0.000101	0.000318	CcSEcCtD
Bupropion—Epistaxis—Doxorubicin—uterine cancer	0.000101	0.000315	CcSEcCtD
Bupropion—Sinusitis—Doxorubicin—uterine cancer	0.0001	0.000314	CcSEcCtD
Bupropion—Visual impairment—Epirubicin—uterine cancer	9.98e-05	0.000313	CcSEcCtD
Bupropion—Erythema multiforme—Epirubicin—uterine cancer	9.79e-05	0.000307	CcSEcCtD
Bupropion—Eye disorder—Epirubicin—uterine cancer	9.68e-05	0.000303	CcSEcCtD
Bupropion—Hypersensitivity—Etoposide—uterine cancer	9.67e-05	0.000303	CcSEcCtD
Bupropion—Tinnitus—Epirubicin—uterine cancer	9.65e-05	0.000302	CcSEcCtD
Bupropion—Haemoglobin—Doxorubicin—uterine cancer	9.63e-05	0.000302	CcSEcCtD
Bupropion—Flushing—Epirubicin—uterine cancer	9.61e-05	0.000301	CcSEcCtD
Bupropion—Cardiac disorder—Epirubicin—uterine cancer	9.61e-05	0.000301	CcSEcCtD
Bupropion—Rhinitis—Doxorubicin—uterine cancer	9.6e-05	0.000301	CcSEcCtD
Bupropion—Haemorrhage—Doxorubicin—uterine cancer	9.58e-05	0.0003	CcSEcCtD
Bupropion—Hepatitis—Doxorubicin—uterine cancer	9.58e-05	0.0003	CcSEcCtD
Bupropion—Hypoaesthesia—Doxorubicin—uterine cancer	9.53e-05	0.000299	CcSEcCtD
Bupropion—Pharyngitis—Doxorubicin—uterine cancer	9.51e-05	0.000298	CcSEcCtD
Bupropion—Urinary tract disorder—Doxorubicin—uterine cancer	9.46e-05	0.000296	CcSEcCtD
Bupropion—Oedema peripheral—Doxorubicin—uterine cancer	9.44e-05	0.000296	CcSEcCtD
Bupropion—Asthenia—Etoposide—uterine cancer	9.42e-05	0.000295	CcSEcCtD
Bupropion—Connective tissue disorder—Doxorubicin—uterine cancer	9.41e-05	0.000295	CcSEcCtD
Bupropion—Angiopathy—Epirubicin—uterine cancer	9.39e-05	0.000294	CcSEcCtD
Bupropion—Urethral disorder—Doxorubicin—uterine cancer	9.39e-05	0.000294	CcSEcCtD
Bupropion—Immune system disorder—Epirubicin—uterine cancer	9.35e-05	0.000293	CcSEcCtD
Bupropion—Mediastinal disorder—Epirubicin—uterine cancer	9.33e-05	0.000292	CcSEcCtD
Bupropion—Chills—Epirubicin—uterine cancer	9.29e-05	0.000291	CcSEcCtD
Bupropion—Pruritus—Etoposide—uterine cancer	9.28e-05	0.000291	CcSEcCtD
Bupropion—Arrhythmia—Epirubicin—uterine cancer	9.25e-05	0.00029	CcSEcCtD
Bupropion—Visual impairment—Doxorubicin—uterine cancer	9.23e-05	0.000289	CcSEcCtD
Bupropion—Alopecia—Epirubicin—uterine cancer	9.15e-05	0.000287	CcSEcCtD
Bupropion—Mental disorder—Epirubicin—uterine cancer	9.07e-05	0.000284	CcSEcCtD
Bupropion—Erythema multiforme—Doxorubicin—uterine cancer	9.06e-05	0.000284	CcSEcCtD
Bupropion—Malnutrition—Epirubicin—uterine cancer	9.01e-05	0.000282	CcSEcCtD
Bupropion—Diarrhoea—Etoposide—uterine cancer	8.98e-05	0.000281	CcSEcCtD
Bupropion—Eye disorder—Doxorubicin—uterine cancer	8.95e-05	0.00028	CcSEcCtD
Bupropion—Tinnitus—Doxorubicin—uterine cancer	8.93e-05	0.00028	CcSEcCtD
Bupropion—Flushing—Doxorubicin—uterine cancer	8.89e-05	0.000279	CcSEcCtD
Bupropion—Cardiac disorder—Doxorubicin—uterine cancer	8.89e-05	0.000279	CcSEcCtD
Bupropion—Flatulence—Epirubicin—uterine cancer	8.88e-05	0.000278	CcSEcCtD
Bupropion—Tension—Epirubicin—uterine cancer	8.84e-05	0.000277	CcSEcCtD
Bupropion—Dysgeusia—Epirubicin—uterine cancer	8.83e-05	0.000276	CcSEcCtD
Bupropion—Nervousness—Epirubicin—uterine cancer	8.75e-05	0.000274	CcSEcCtD
Bupropion—Back pain—Epirubicin—uterine cancer	8.72e-05	0.000273	CcSEcCtD
Bupropion—Angiopathy—Doxorubicin—uterine cancer	8.69e-05	0.000272	CcSEcCtD
Bupropion—Dizziness—Etoposide—uterine cancer	8.68e-05	0.000272	CcSEcCtD
Bupropion—Muscle spasms—Epirubicin—uterine cancer	8.67e-05	0.000271	CcSEcCtD
Bupropion—Immune system disorder—Doxorubicin—uterine cancer	8.65e-05	0.000271	CcSEcCtD
Bupropion—Mediastinal disorder—Doxorubicin—uterine cancer	8.63e-05	0.00027	CcSEcCtD
Bupropion—Chills—Doxorubicin—uterine cancer	8.6e-05	0.000269	CcSEcCtD
Bupropion—Arrhythmia—Doxorubicin—uterine cancer	8.56e-05	0.000268	CcSEcCtD
Bupropion—Vision blurred—Epirubicin—uterine cancer	8.49e-05	0.000266	CcSEcCtD
Bupropion—Alopecia—Doxorubicin—uterine cancer	8.47e-05	0.000265	CcSEcCtD
Bupropion—Mental disorder—Doxorubicin—uterine cancer	8.39e-05	0.000263	CcSEcCtD
Bupropion—Ill-defined disorder—Epirubicin—uterine cancer	8.36e-05	0.000262	CcSEcCtD
Bupropion—Vomiting—Etoposide—uterine cancer	8.34e-05	0.000261	CcSEcCtD
Bupropion—Malnutrition—Doxorubicin—uterine cancer	8.34e-05	0.000261	CcSEcCtD
Bupropion—Anaemia—Epirubicin—uterine cancer	8.33e-05	0.000261	CcSEcCtD
Bupropion—Agitation—Epirubicin—uterine cancer	8.28e-05	0.000259	CcSEcCtD
Bupropion—Rash—Etoposide—uterine cancer	8.27e-05	0.000259	CcSEcCtD
Bupropion—Dermatitis—Etoposide—uterine cancer	8.27e-05	0.000259	CcSEcCtD
Bupropion—Headache—Etoposide—uterine cancer	8.22e-05	0.000258	CcSEcCtD
Bupropion—Flatulence—Doxorubicin—uterine cancer	8.22e-05	0.000257	CcSEcCtD
Bupropion—Tension—Doxorubicin—uterine cancer	8.18e-05	0.000256	CcSEcCtD
Bupropion—Dysgeusia—Doxorubicin—uterine cancer	8.17e-05	0.000256	CcSEcCtD
Bupropion—Malaise—Epirubicin—uterine cancer	8.13e-05	0.000255	CcSEcCtD
Bupropion—Nervousness—Doxorubicin—uterine cancer	8.1e-05	0.000254	CcSEcCtD
Bupropion—Vertigo—Epirubicin—uterine cancer	8.1e-05	0.000254	CcSEcCtD
Bupropion—Syncope—Epirubicin—uterine cancer	8.08e-05	0.000253	CcSEcCtD
Bupropion—Leukopenia—Epirubicin—uterine cancer	8.07e-05	0.000253	CcSEcCtD
Bupropion—Back pain—Doxorubicin—uterine cancer	8.07e-05	0.000253	CcSEcCtD
Bupropion—Muscle spasms—Doxorubicin—uterine cancer	8.02e-05	0.000251	CcSEcCtD
Bupropion—Palpitations—Epirubicin—uterine cancer	7.96e-05	0.000249	CcSEcCtD
Bupropion—Loss of consciousness—Epirubicin—uterine cancer	7.92e-05	0.000248	CcSEcCtD
Bupropion—Cough—Epirubicin—uterine cancer	7.87e-05	0.000246	CcSEcCtD
Bupropion—Vision blurred—Doxorubicin—uterine cancer	7.86e-05	0.000246	CcSEcCtD
Bupropion—Convulsion—Epirubicin—uterine cancer	7.81e-05	0.000245	CcSEcCtD
Bupropion—Nausea—Etoposide—uterine cancer	7.79e-05	0.000244	CcSEcCtD
Bupropion—Hypertension—Epirubicin—uterine cancer	7.78e-05	0.000244	CcSEcCtD
Bupropion—Ill-defined disorder—Doxorubicin—uterine cancer	7.74e-05	0.000242	CcSEcCtD
Bupropion—Anaemia—Doxorubicin—uterine cancer	7.71e-05	0.000241	CcSEcCtD
Bupropion—Chest pain—Epirubicin—uterine cancer	7.67e-05	0.00024	CcSEcCtD
Bupropion—Myalgia—Epirubicin—uterine cancer	7.67e-05	0.00024	CcSEcCtD
Bupropion—Arthralgia—Epirubicin—uterine cancer	7.67e-05	0.00024	CcSEcCtD
Bupropion—Agitation—Doxorubicin—uterine cancer	7.66e-05	0.00024	CcSEcCtD
Bupropion—Anxiety—Epirubicin—uterine cancer	7.65e-05	0.00024	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.62e-05	0.000239	CcSEcCtD
Bupropion—Discomfort—Epirubicin—uterine cancer	7.58e-05	0.000237	CcSEcCtD
Bupropion—Malaise—Doxorubicin—uterine cancer	7.52e-05	0.000236	CcSEcCtD
Bupropion—Dry mouth—Epirubicin—uterine cancer	7.5e-05	0.000235	CcSEcCtD
Bupropion—Vertigo—Doxorubicin—uterine cancer	7.49e-05	0.000235	CcSEcCtD
Bupropion—Syncope—Doxorubicin—uterine cancer	7.48e-05	0.000234	CcSEcCtD
Bupropion—Leukopenia—Doxorubicin—uterine cancer	7.46e-05	0.000234	CcSEcCtD
Bupropion—Confusional state—Epirubicin—uterine cancer	7.42e-05	0.000232	CcSEcCtD
Bupropion—Palpitations—Doxorubicin—uterine cancer	7.37e-05	0.000231	CcSEcCtD
Bupropion—Oedema—Epirubicin—uterine cancer	7.36e-05	0.00023	CcSEcCtD
Bupropion—Anaphylactic shock—Epirubicin—uterine cancer	7.36e-05	0.00023	CcSEcCtD
Bupropion—Loss of consciousness—Doxorubicin—uterine cancer	7.33e-05	0.00023	CcSEcCtD
Bupropion—Infection—Epirubicin—uterine cancer	7.31e-05	0.000229	CcSEcCtD
Bupropion—Cough—Doxorubicin—uterine cancer	7.28e-05	0.000228	CcSEcCtD
Bupropion—Shock—Epirubicin—uterine cancer	7.24e-05	0.000227	CcSEcCtD
Bupropion—Convulsion—Doxorubicin—uterine cancer	7.23e-05	0.000226	CcSEcCtD
Bupropion—Nervous system disorder—Epirubicin—uterine cancer	7.21e-05	0.000226	CcSEcCtD
Bupropion—Thrombocytopenia—Epirubicin—uterine cancer	7.2e-05	0.000226	CcSEcCtD
Bupropion—Hypertension—Doxorubicin—uterine cancer	7.2e-05	0.000226	CcSEcCtD
Bupropion—Tachycardia—Epirubicin—uterine cancer	7.18e-05	0.000225	CcSEcCtD
Bupropion—Skin disorder—Epirubicin—uterine cancer	7.14e-05	0.000224	CcSEcCtD
Bupropion—Hyperhidrosis—Epirubicin—uterine cancer	7.11e-05	0.000223	CcSEcCtD
Bupropion—Arthralgia—Doxorubicin—uterine cancer	7.1e-05	0.000222	CcSEcCtD
Bupropion—Myalgia—Doxorubicin—uterine cancer	7.1e-05	0.000222	CcSEcCtD
Bupropion—Chest pain—Doxorubicin—uterine cancer	7.1e-05	0.000222	CcSEcCtD
Bupropion—Anxiety—Doxorubicin—uterine cancer	7.08e-05	0.000222	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	7.05e-05	0.000221	CcSEcCtD
Bupropion—Discomfort—Doxorubicin—uterine cancer	7.01e-05	0.00022	CcSEcCtD
Bupropion—Anorexia—Epirubicin—uterine cancer	7.01e-05	0.00022	CcSEcCtD
Bupropion—Dry mouth—Doxorubicin—uterine cancer	6.94e-05	0.000218	CcSEcCtD
Bupropion—Hypotension—Epirubicin—uterine cancer	6.87e-05	0.000215	CcSEcCtD
Bupropion—Confusional state—Doxorubicin—uterine cancer	6.86e-05	0.000215	CcSEcCtD
Bupropion—Oedema—Doxorubicin—uterine cancer	6.81e-05	0.000213	CcSEcCtD
Bupropion—Anaphylactic shock—Doxorubicin—uterine cancer	6.81e-05	0.000213	CcSEcCtD
Bupropion—Infection—Doxorubicin—uterine cancer	6.76e-05	0.000212	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.7e-05	0.00021	CcSEcCtD
Bupropion—Shock—Doxorubicin—uterine cancer	6.7e-05	0.00021	CcSEcCtD
Bupropion—Nervous system disorder—Doxorubicin—uterine cancer	6.67e-05	0.000209	CcSEcCtD
Bupropion—Thrombocytopenia—Doxorubicin—uterine cancer	6.66e-05	0.000209	CcSEcCtD
Bupropion—Insomnia—Epirubicin—uterine cancer	6.65e-05	0.000208	CcSEcCtD
Bupropion—Tachycardia—Doxorubicin—uterine cancer	6.64e-05	0.000208	CcSEcCtD
Bupropion—Skin disorder—Doxorubicin—uterine cancer	6.61e-05	0.000207	CcSEcCtD
Bupropion—Paraesthesia—Epirubicin—uterine cancer	6.61e-05	0.000207	CcSEcCtD
Bupropion—Hyperhidrosis—Doxorubicin—uterine cancer	6.58e-05	0.000206	CcSEcCtD
Bupropion—Dyspnoea—Epirubicin—uterine cancer	6.56e-05	0.000205	CcSEcCtD
Bupropion—Somnolence—Epirubicin—uterine cancer	6.54e-05	0.000205	CcSEcCtD
Bupropion—Anorexia—Doxorubicin—uterine cancer	6.49e-05	0.000203	CcSEcCtD
Bupropion—Dyspepsia—Epirubicin—uterine cancer	6.48e-05	0.000203	CcSEcCtD
Bupropion—Decreased appetite—Epirubicin—uterine cancer	6.39e-05	0.0002	CcSEcCtD
Bupropion—Hypotension—Doxorubicin—uterine cancer	6.36e-05	0.000199	CcSEcCtD
Bupropion—Gastrointestinal disorder—Epirubicin—uterine cancer	6.35e-05	0.000199	CcSEcCtD
Bupropion—Fatigue—Epirubicin—uterine cancer	6.34e-05	0.000199	CcSEcCtD
Bupropion—Pain—Epirubicin—uterine cancer	6.29e-05	0.000197	CcSEcCtD
Bupropion—Constipation—Epirubicin—uterine cancer	6.29e-05	0.000197	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Doxorubicin—uterine cancer	6.2e-05	0.000194	CcSEcCtD
Bupropion—Insomnia—Doxorubicin—uterine cancer	6.16e-05	0.000193	CcSEcCtD
Bupropion—Paraesthesia—Doxorubicin—uterine cancer	6.11e-05	0.000191	CcSEcCtD
Bupropion—Dyspnoea—Doxorubicin—uterine cancer	6.07e-05	0.00019	CcSEcCtD
Bupropion—Feeling abnormal—Epirubicin—uterine cancer	6.06e-05	0.00019	CcSEcCtD
Bupropion—Somnolence—Doxorubicin—uterine cancer	6.05e-05	0.00019	CcSEcCtD
Bupropion—Gastrointestinal pain—Epirubicin—uterine cancer	6.02e-05	0.000188	CcSEcCtD
Bupropion—Dyspepsia—Doxorubicin—uterine cancer	5.99e-05	0.000188	CcSEcCtD
Bupropion—Decreased appetite—Doxorubicin—uterine cancer	5.92e-05	0.000185	CcSEcCtD
Bupropion—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.88e-05	0.000184	CcSEcCtD
Bupropion—Fatigue—Doxorubicin—uterine cancer	5.87e-05	0.000184	CcSEcCtD
Bupropion—Urticaria—Epirubicin—uterine cancer	5.84e-05	0.000183	CcSEcCtD
Bupropion—Pain—Doxorubicin—uterine cancer	5.82e-05	0.000182	CcSEcCtD
Bupropion—Constipation—Doxorubicin—uterine cancer	5.82e-05	0.000182	CcSEcCtD
Bupropion—Abdominal pain—Epirubicin—uterine cancer	5.81e-05	0.000182	CcSEcCtD
Bupropion—Body temperature increased—Epirubicin—uterine cancer	5.81e-05	0.000182	CcSEcCtD
Bupropion—Feeling abnormal—Doxorubicin—uterine cancer	5.61e-05	0.000176	CcSEcCtD
Bupropion—Gastrointestinal pain—Doxorubicin—uterine cancer	5.57e-05	0.000174	CcSEcCtD
Bupropion—Hypersensitivity—Epirubicin—uterine cancer	5.42e-05	0.00017	CcSEcCtD
Bupropion—Urticaria—Doxorubicin—uterine cancer	5.41e-05	0.000169	CcSEcCtD
Bupropion—Abdominal pain—Doxorubicin—uterine cancer	5.38e-05	0.000169	CcSEcCtD
Bupropion—Body temperature increased—Doxorubicin—uterine cancer	5.38e-05	0.000169	CcSEcCtD
Bupropion—Asthenia—Epirubicin—uterine cancer	5.28e-05	0.000165	CcSEcCtD
Bupropion—Pruritus—Epirubicin—uterine cancer	5.2e-05	0.000163	CcSEcCtD
Bupropion—Diarrhoea—Epirubicin—uterine cancer	5.03e-05	0.000158	CcSEcCtD
Bupropion—Hypersensitivity—Doxorubicin—uterine cancer	5.01e-05	0.000157	CcSEcCtD
Bupropion—Asthenia—Doxorubicin—uterine cancer	4.88e-05	0.000153	CcSEcCtD
Bupropion—Dizziness—Epirubicin—uterine cancer	4.86e-05	0.000152	CcSEcCtD
Bupropion—Pruritus—Doxorubicin—uterine cancer	4.82e-05	0.000151	CcSEcCtD
Bupropion—Vomiting—Epirubicin—uterine cancer	4.68e-05	0.000147	CcSEcCtD
Bupropion—Diarrhoea—Doxorubicin—uterine cancer	4.66e-05	0.000146	CcSEcCtD
Bupropion—Rash—Epirubicin—uterine cancer	4.64e-05	0.000145	CcSEcCtD
Bupropion—Dermatitis—Epirubicin—uterine cancer	4.63e-05	0.000145	CcSEcCtD
Bupropion—Headache—Epirubicin—uterine cancer	4.61e-05	0.000144	CcSEcCtD
Bupropion—Dizziness—Doxorubicin—uterine cancer	4.5e-05	0.000141	CcSEcCtD
Bupropion—Nausea—Epirubicin—uterine cancer	4.37e-05	0.000137	CcSEcCtD
Bupropion—Vomiting—Doxorubicin—uterine cancer	4.33e-05	0.000136	CcSEcCtD
Bupropion—Rash—Doxorubicin—uterine cancer	4.29e-05	0.000134	CcSEcCtD
Bupropion—Dermatitis—Doxorubicin—uterine cancer	4.29e-05	0.000134	CcSEcCtD
Bupropion—Headache—Doxorubicin—uterine cancer	4.26e-05	0.000134	CcSEcCtD
Bupropion—Nausea—Doxorubicin—uterine cancer	4.04e-05	0.000127	CcSEcCtD
Bupropion—CYP2D6—Metapathway biotransformation—AKR1B1—uterine cancer	1.59e-05	0.00463	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	1.57e-05	0.00459	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.54e-05	0.00448	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	1.47e-05	0.00429	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	1.46e-05	0.00427	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	1.45e-05	0.00422	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	1.44e-05	0.00421	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	1.44e-05	0.00421	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—AKR1C1—uterine cancer	1.42e-05	0.00414	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.42e-05	0.00413	CbGpPWpGaD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.39e-05	0.00407	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	1.39e-05	0.00404	CbGpPWpGaD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.38e-05	0.00401	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	1.37e-05	0.00399	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	1.36e-05	0.00396	CbGpPWpGaD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	1.35e-05	0.00394	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	1.35e-05	0.00392	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	1.34e-05	0.00391	CbGpPWpGaD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.33e-05	0.00389	CbGpPWpGaD
Bupropion—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	1.33e-05	0.00388	CbGpPWpGaD
Bupropion—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.32e-05	0.00386	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	1.29e-05	0.00377	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	1.26e-05	0.00369	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	1.26e-05	0.00369	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.25e-05	0.00366	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—GPX3—uterine cancer	1.25e-05	0.00364	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.19e-05	0.00346	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—CYP11A1—uterine cancer	1.17e-05	0.00342	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	1.17e-05	0.0034	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP11A1—uterine cancer	1.16e-05	0.00338	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	1.16e-05	0.00337	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	1.15e-05	0.00336	CbGpPWpGaD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.13e-05	0.0033	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	1.12e-05	0.00326	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—AKR1C3—uterine cancer	1.09e-05	0.00319	CbGpPWpGaD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.08e-05	0.00314	CbGpPWpGaD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.06e-05	0.0031	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.04e-05	0.00304	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.04e-05	0.00303	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	1.02e-05	0.00298	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	1.02e-05	0.00297	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	1.01e-05	0.00296	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—uterine cancer	1.01e-05	0.00294	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	1.01e-05	0.00293	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	9.99e-06	0.00291	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	9.87e-06	0.00288	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	9.85e-06	0.00287	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	9.63e-06	0.00281	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	9.55e-06	0.00279	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	9.5e-06	0.00277	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	9.42e-06	0.00275	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	8.97e-06	0.00262	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	8.89e-06	0.00259	CbGpPWpGaD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.72e-06	0.00254	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	8.67e-06	0.00253	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	8.63e-06	0.00252	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	8.51e-06	0.00248	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	8.48e-06	0.00247	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	8.16e-06	0.00238	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	8.05e-06	0.00235	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	7.83e-06	0.00228	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	7.83e-06	0.00228	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	7.62e-06	0.00222	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	7.6e-06	0.00222	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—HRAS—uterine cancer	7.57e-06	0.00221	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.53e-06	0.0022	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.53e-06	0.0022	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.24e-06	0.00211	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	7.09e-06	0.00207	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	7.03e-06	0.00205	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	6.99e-06	0.00204	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	6.93e-06	0.00202	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	6.87e-06	0.00201	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	6.87e-06	0.00201	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—NDUFB11—uterine cancer	6.79e-06	0.00198	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SRD5A2—uterine cancer	6.79e-06	0.00198	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	6.69e-06	0.00195	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	6.51e-06	0.0019	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	6.43e-06	0.00188	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	6.3e-06	0.00184	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	6.21e-06	0.00181	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.13e-06	0.00179	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.13e-06	0.00179	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	6e-06	0.00175	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	5.92e-06	0.00173	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	5.87e-06	0.00171	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—HRAS—uterine cancer	5.8e-06	0.00169	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	5.54e-06	0.00161	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.53e-06	0.00161	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—NDUFB11—uterine cancer	5.48e-06	0.0016	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SRD5A2—uterine cancer	5.48e-06	0.0016	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—NDUFB11—uterine cancer	5.37e-06	0.00157	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SRD5A2—uterine cancer	5.37e-06	0.00157	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.24e-06	0.00153	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.24e-06	0.00153	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—STAR—uterine cancer	4.91e-06	0.00143	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—AKR1B1—uterine cancer	4.91e-06	0.00143	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.7e-06	0.00137	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SRD5A2—uterine cancer	4.64e-06	0.00135	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—NDUFB11—uterine cancer	4.64e-06	0.00135	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.63e-06	0.00135	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.57e-06	0.00133	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.51e-06	0.00131	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.5e-06	0.00131	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.25e-06	0.00124	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—AKR1B1—uterine cancer	3.96e-06	0.00116	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—STAR—uterine cancer	3.96e-06	0.00116	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—AKR1B1—uterine cancer	3.88e-06	0.00113	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—STAR—uterine cancer	3.88e-06	0.00113	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—POLD1—uterine cancer	3.85e-06	0.00112	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.84e-06	0.00112	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—NDUFB11—uterine cancer	3.81e-06	0.00111	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SRD5A2—uterine cancer	3.81e-06	0.00111	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SRD5A2—uterine cancer	3.78e-06	0.0011	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—NDUFB11—uterine cancer	3.78e-06	0.0011	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.67e-06	0.00107	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—HRAS—uterine cancer	3.66e-06	0.00107	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—AKR1C1—uterine cancer	3.6e-06	0.00105	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.46e-06	0.00101	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—STAR—uterine cancer	3.35e-06	0.000978	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—AKR1B1—uterine cancer	3.35e-06	0.000978	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.31e-06	0.000967	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SRD5A2—uterine cancer	3.23e-06	0.000941	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—NDUFB11—uterine cancer	3.23e-06	0.000941	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—RRM2—uterine cancer	3.21e-06	0.000937	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.13e-06	0.000914	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—DCN—uterine cancer	3.12e-06	0.000909	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—POLD1—uterine cancer	3.11e-06	0.000907	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—POLD1—uterine cancer	3.04e-06	0.000888	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.96e-06	0.000863	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP11A1—uterine cancer	2.94e-06	0.000857	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.91e-06	0.000848	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—AKR1C1—uterine cancer	2.85e-06	0.000831	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—HRAS—uterine cancer	2.8e-06	0.000818	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—AKR1C3—uterine cancer	2.77e-06	0.000809	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—STAR—uterine cancer	2.75e-06	0.000803	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.75e-06	0.000803	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.73e-06	0.000796	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—STAR—uterine cancer	2.73e-06	0.000796	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.7e-06	0.000787	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—POLD1—uterine cancer	2.63e-06	0.000768	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—RRM2—uterine cancer	2.59e-06	0.000756	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—RRM2—uterine cancer	2.54e-06	0.00074	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—DCN—uterine cancer	2.52e-06	0.000734	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.49e-06	0.000726	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.49e-06	0.000726	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—DCN—uterine cancer	2.46e-06	0.000719	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—AKR1C1—uterine cancer	2.46e-06	0.000718	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP11A1—uterine cancer	2.37e-06	0.000691	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—STAR—uterine cancer	2.33e-06	0.00068	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—AKR1B1—uterine cancer	2.33e-06	0.00068	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP11A1—uterine cancer	2.32e-06	0.000677	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.31e-06	0.000672	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—AKR1C3—uterine cancer	2.24e-06	0.000653	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—RRM2—uterine cancer	2.19e-06	0.00064	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—AKR1C3—uterine cancer	2.19e-06	0.000639	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—STK11—uterine cancer	2.16e-06	0.00063	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP19A1—uterine cancer	2.16e-06	0.00063	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—POLD1—uterine cancer	2.16e-06	0.00063	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—POLD1—uterine cancer	2.14e-06	0.000625	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—DCN—uterine cancer	2.13e-06	0.000621	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.02e-06	0.000589	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP11A1—uterine cancer	2.01e-06	0.000585	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—AKR1C1—uterine cancer	2e-06	0.000584	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.89e-06	0.000553	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—POLD1—uterine cancer	1.83e-06	0.000534	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—RRM2—uterine cancer	1.8e-06	0.000525	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—STAR—uterine cancer	1.8e-06	0.000525	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.8e-06	0.000525	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—RRM2—uterine cancer	1.79e-06	0.000521	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—DCN—uterine cancer	1.75e-06	0.00051	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—STK11—uterine cancer	1.74e-06	0.000509	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.74e-06	0.000509	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—DCN—uterine cancer	1.73e-06	0.000506	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.71e-06	0.000499	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.71e-06	0.000498	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—STK11—uterine cancer	1.71e-06	0.000498	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.65e-06	0.000481	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.63e-06	0.000476	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—MTHFR—uterine cancer	1.62e-06	0.000474	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.56e-06	0.000454	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.54e-06	0.00045	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—RRM2—uterine cancer	1.53e-06	0.000445	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—DCN—uterine cancer	1.48e-06	0.000432	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.48e-06	0.000431	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—STK11—uterine cancer	1.48e-06	0.000431	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—POLD1—uterine cancer	1.41e-06	0.000412	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.4e-06	0.000407	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.39e-06	0.000404	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.32e-06	0.000385	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.32e-06	0.000385	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.32e-06	0.000384	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—MTHFR—uterine cancer	1.31e-06	0.000382	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—MTHFR—uterine cancer	1.28e-06	0.000374	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—STK11—uterine cancer	1.21e-06	0.000354	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.21e-06	0.000354	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—STK11—uterine cancer	1.2e-06	0.00035	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.2e-06	0.00035	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—RRM2—uterine cancer	1.18e-06	0.000343	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—DCN—uterine cancer	1.14e-06	0.000333	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.13e-06	0.000329	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—MTHFR—uterine cancer	1.11e-06	0.000324	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.08e-06	0.000314	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.08e-06	0.000314	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—STK11—uterine cancer	1.03e-06	0.000299	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.03e-06	0.000299	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.02e-06	0.000297	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.78e-07	0.000285	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.64e-07	0.000281	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.19e-07	0.000268	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—MTHFR—uterine cancer	9.11e-07	0.000266	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTEN—uterine cancer	9.03e-07	0.000264	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—MTHFR—uterine cancer	9.03e-07	0.000263	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—EP300—uterine cancer	8.62e-07	0.000251	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.96e-07	0.000232	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—STK11—uterine cancer	7.92e-07	0.000231	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP19A1—uterine cancer	7.92e-07	0.000231	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—MTHFR—uterine cancer	7.72e-07	0.000225	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTEN—uterine cancer	7.29e-07	0.000213	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTEN—uterine cancer	7.14e-07	0.000208	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—EP300—uterine cancer	6.95e-07	0.000203	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—EP300—uterine cancer	6.81e-07	0.000199	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.8e-07	0.000198	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CA—uterine cancer	6.37e-07	0.000186	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTEN—uterine cancer	6.17e-07	0.00018	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—MTHFR—uterine cancer	5.95e-07	0.000174	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—EP300—uterine cancer	5.89e-07	0.000172	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—AKT1—uterine cancer	5.21e-07	0.000152	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CA—uterine cancer	5.14e-07	0.00015	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTEN—uterine cancer	5.07e-07	0.000148	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CA—uterine cancer	5.04e-07	0.000147	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTEN—uterine cancer	5.02e-07	0.000147	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—EP300—uterine cancer	4.83e-07	0.000141	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—EP300—uterine cancer	4.79e-07	0.00014	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CA—uterine cancer	4.35e-07	0.000127	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTEN—uterine cancer	4.29e-07	0.000125	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—AKT1—uterine cancer	4.2e-07	0.000123	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—AKT1—uterine cancer	4.11e-07	0.00012	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—EP300—uterine cancer	4.09e-07	0.000119	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CA—uterine cancer	3.57e-07	0.000104	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—AKT1—uterine cancer	3.56e-07	0.000104	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.54e-07	0.000103	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTEN—uterine cancer	3.31e-07	9.66e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—EP300—uterine cancer	3.16e-07	9.21e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CA—uterine cancer	3.03e-07	8.83e-05	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—AKT1—uterine cancer	2.92e-07	8.52e-05	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—AKT1—uterine cancer	2.89e-07	8.44e-05	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—AKT1—uterine cancer	2.47e-07	7.22e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.34e-07	6.82e-05	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—AKT1—uterine cancer	1.91e-07	5.57e-05	CbGpPWpGaD
